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 ITEM RECOMMENDATION 
Section/ 
Paragraph 
Title 1 Provide as accurate and concise a description of the content of the article 
as possible. 
      
Abstract 2 Provide an accurate summary of the background, research objectives, 
including details of the species or strain of animal used, key methods, 
principal findings and conclusions of the study. 
      
INTRODUCTION  
Background 3 a. Include sufficient scientific background (including relevant references to 
previous work) to understand the motivation and context for the study, 
and explain the experimental approach and rationale. 
b. Explain how and why the animal species and model being used can 
address the scientific objectives and, where appropriate, the study’s 
relevance to human biology. 
      
Objectives 4 Clearly describe the primary and any secondary objectives of the study, or 
specific hypotheses being tested. 
      
METHODS  
Ethical statement 5 Indicate the nature of the ethical review permissions, relevant licences (e.g. 
Animal [Scientific Procedures] Act 1986), and national or institutional 
guidelines for the care and use of animals, that cover the research. 
      
Study design 6 For each experiment, give brief details of the study design including: 
a. The number of experimental and control groups. 
b. Any steps taken to minimise the effects of subjective bias when 
allocating animals to treatment (e.g. randomisation procedure) and when 
assessing results (e.g. if done, describe who was blinded and when). 
c. The experimental unit (e.g. a single animal, group or cage of animals). 
A time-line diagram or flow chart can be useful to illustrate how complex 
study designs were carried out. 
      
Experimental 
procedures 
7 For each experiment and each experimental group, including controls, 
provide precise details of all procedures carried out. For example: 
a. How (e.g. drug formulation and dose, site and route of administration, 
anaesthesia and analgesia used [including monitoring], surgical 
procedure, method of euthanasia). Provide details of any specialist 
equipment used, including supplier(s). 
b. When (e.g. time of day). 
c. Where (e.g. home cage, laboratory, water maze). 
d. Why (e.g. rationale for choice of specific anaesthetic, route of 
administration, drug dose used). 
      
Experimental 
animals 
8 a. Provide details of the animals used, including species, strain, sex, 
developmental stage (e.g. mean or median age plus age range) and 
weight (e.g. mean or median weight plus weight range). 
b. Provide further relevant information such as the source of animals, 
international strain nomenclature, genetic modification status (e.g. 
knock-out or transgenic), genotype, health/immune status, drug or test 
naïve, previous procedures, etc. 
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 Housing and 
husbandry 
9 Provide details of: 
a. Housing (type of facility e.g. specific pathogen free [SPF]; type of cage or 
housing; bedding material; number of cage companions; tank shape and 
material etc. for fish). 
b. Husbandry conditions (e.g. breeding programme, light/dark cycle, 
temperature, quality of water etc for fish, type of food, access to food 
and water, environmental enrichment). 
c. Welfare-related assessments and interventions that were carried out 
prior to, during, or after the experiment. 
      
Sample size 10 a. Specify the total number of animals used in each experiment, and the 
number of animals in each experimental group.  
b. Explain how the number of animals was arrived at. Provide details of any 
sample size calculation used. 
c. Indicate the number of independent replications of each experiment, if 
relevant. 
      
Allocating 
animals to 
experimental 
groups 
11 a. Give full details of how animals were allocated to experimental groups, 
including randomisation or matching if done. 
b. Describe the order in which the animals in the different experimental 
groups were treated and assessed. 
      
Experimental 
outcomes 
12 Clearly define the primary and secondary experimental outcomes assessed 
(e.g. cell death, molecular markers, behavioural changes). 
      
Statistical 
methods 
13 a. Provide details of the statistical methods used for each analysis. 
b. Specify the unit of analysis for each dataset (e.g. single animal, group of 
animals, single neuron). 
c. Describe any methods used to assess whether the data met the 
assumptions of the statistical approach. 
      
RESULTS  
Baseline data 14 For each experimental group, report relevant characteristics and health 
status of animals (e.g. weight, microbiological status, and drug or test naïve) 
prior to treatment or testing. (This information can often be tabulated). 
      
Numbers 
analysed 
15 a. Report the number of animals in each group included in each analysis. 
Report absolute numbers (e.g. 10/20, not 50%
2
). 
b. If any animals or data were not included in the analysis, explain why. 
      
Outcomes and 
estimation 
16 Report the results for each analysis carried out, with a measure of precision 
(e.g. standard error or confidence interval). 
      
Adverse events 17 a. Give details of all important adverse events in each experimental group. 
b. Describe any modifications to the experimental protocols made to 
reduce adverse events. 
      
DISCUSSION  
Interpretation/ 
scientific 
implications 
18 a. Interpret the results, taking into account the study objectives and 
hypotheses, current theory and other relevant studies in the literature. 
b. Comment on the study limitations including any potential sources of bias, 
any limitations of the animal model, and the imprecision associated with 
the results
2
. 
c. Describe any implications of your experimental methods or findings for 
the replacement, refinement or reduction (the 3Rs) of the use of animals 
in research. 
      
Generalisability/ 
translation 
19 Comment on whether, and how, the findings of this study are likely to 
translate to other species or systems, including any relevance to human 
biology. 
      
Funding 20 List all funding sources (including grant number) and the role of the 
funder(s) in the study. 
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